Polymyxin B Induces Apoptosis in Kidney Proximal Tubular Cells
暂无分享,去创建一个
Roger L. Nation | Tony Velkov | Jian Li | J. Li | R. Nation | T. Velkov | M. Azad | Jinhua Li | Mohammad A. K. Azad | Ben A. Finnin | Anima Poudyal | Kathryn Davis | Prue A. Hill | Jinhua Li | K. Davis | A. Poudyal | B. A. Finnin | P. A. Hill
[1] P. van der Smissen,et al. Gentamicin-induced apoptosis in LLC-PK1 cells: involvement of lysosomes and mitochondria. , 2005, Toxicology and applied pharmacology.
[2] D. Calfee,et al. Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy. , 2012, The Journal of infection.
[3] Jian Li,et al. Melatonin Attenuates Colistin-Induced Nephrotoxicity in Rats , 2011, Antimicrobial Agents and Chemotherapy.
[4] J. Bartlett,et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] H. Lassmann,et al. Detection of DNA fragmentation in apoptosis: application of in situ nick translation to cell culture systems and tissue sections. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[6] V. Toscano,et al. Thyroid Hormone T3 Counteracts STZ Induced Diabetes in Mouse , 2011, PloS one.
[7] J. Turnidge,et al. fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models. , 2010, The Journal of antimicrobial chemotherapy.
[8] M. Falagas,et al. Nephrotoxicity of intravenous colistin: a prospective evaluation. , 2005, International journal of antimicrobial agents.
[9] Matthew E Falagas,et al. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] Joshua D. Hartzell,et al. Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] V. Cryns,et al. Proteases to die for. , 1998, Genes & development.
[12] E. Ozyilmaz,et al. Could nephrotoxicity due to colistin be ameliorated with the use of N-acetylcysteine? , 2010, Intensive Care Medicine.
[13] C. Landersdorfer,et al. Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] Seamus J. Martin,et al. Phosphatidylserine Externalization during CD95-induced Apoptosis of Cells and Cytoplasts Requires ICE/CED-3 Protease Activity* , 1996, The Journal of Biological Chemistry.
[15] Mirian Watanabe,et al. Role of Heme Oxygenase-1 in Polymyxin B-Induced Nephrotoxicity in Rats , 2012, Antimicrobial Agents and Chemotherapy.
[16] A. Zavascki,et al. Polymyxin B versus other antimicrobials for the treatment of pseudomonas aeruginosa bacteraemia. , 2011, The Journal of antimicrobial chemotherapy.
[17] M. Raff,et al. Programmed Cell Death in Animal Development , 1997, Cell.
[18] A Forrest,et al. Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients , 2011, Antimicrobial Agents and Chemotherapy.
[19] J. Li,et al. Pharmacokinetics of intravenous polymyxin B in critically ill patients. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] S. Nagata,et al. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis , 1998, Nature.
[21] M. Falagas,et al. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies , 2006, Critical care.
[22] J. López-Novoa,et al. An integrative overview on the mechanisms underlying the renal tubular cytotoxicity of gentamicin. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[23] R A Knight,et al. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes , 2009, Cell Death and Differentiation.
[24] S. Ben‐Sasson,et al. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.
[25] E. Bae,et al. Renoprotective effects of paricalcitol on gentamicin-induced kidney injury in rats. , 2010, American journal of physiology. Renal physiology.
[26] R. Nation,et al. Colistin in the 21st century , 2009, Current opinion in infectious diseases.
[27] G. Bridi,et al. Recovery from colistimethate nephrotoxicity. , 1970, Annals of internal medicine.
[28] M. Vaara,et al. Novel polymyxin derivatives are less cytotoxic than polymyxin B to renal proximal tubular cells , 2012, Peptides.
[29] Y Li,et al. [Mitochondria and apoptosis]. , 2000, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].
[30] A. Wyllie. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation , 1980, Nature.
[31] Ming Hu,et al. Characterization of Polymyxin B-Induced Nephrotoxicity: Implications for Dosing Regimen Design , 2012, Antimicrobial Agents and Chemotherapy.
[32] A. Zavascki,et al. The impact of polymyxin B dosage on in-hospital mortality of patients treated with this antibiotic. , 2010, The Journal of antimicrobial chemotherapy.
[33] D. Graham,et al. Effects of Large Doses of Colistin Sulphomethate Sodium on Renal Function , 1970, British medical journal.
[34] J. Bartlett,et al. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[35] J. Persson,et al. Induction of apoptosis by staurosporine involves the inhibition of expression of the major cell cycle proteins at the G(2)/m checkpoint accompanied by alterations in Erk and Akt kinase activities. , 2009, Anticancer research.
[36] D. Feingold,et al. BASIS FOR THE SELECTIVITY OF ACTION OF THE POLYMYXIN ANTIBIOTICS ON CELL MEMBRANES * , 1974, Annals of the New York Academy of Sciences.
[37] O. Kwon,et al. Differential regulation of B/K protein expression in proximal and distal tubules of rat kidneys with ischemia-reperfusion injury. , 2007, American journal of physiology. Renal physiology.
[38] V. Fadok,et al. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes , 1998, Cell Death and Differentiation.
[39] Ding-ping Yang,et al. Irbesartan attenuates contrast media-induced NRK-52E cells apoptosis. , 2006, Pharmacological research.
[40] A. Wyllie,et al. Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.
[41] J. Turnidge,et al. Use of High-Performance Liquid Chromatography To Study the Pharmacokinetics of Colistin Sulfate in Rats following Intravenous Administration , 2003, Antimicrobial Agents and Chemotherapy.
[42] G. Dong,et al. The pathological role of Bax in cisplatin nephrotoxicity. , 2007, Kidney international.
[43] M. Hengartner. The biochemistry of apoptosis , 2000, Nature.
[44] J. Li,et al. Ascorbic acid protects against the nephrotoxicity and apoptosis caused by colistin and affects its pharmacokinetics. , 2012, The Journal of antimicrobial chemotherapy.
[45] K. Nitta,et al. Eicosapentaenoic acid restores diabetic tubular injury through regulating oxidative stress and mitochondrial apoptosis. , 2010, American journal of physiology. Renal physiology.
[46] C. Kunin. Binding of antibiotics to tissue homogenates. , 1970, The Journal of infectious diseases.
[47] A. Schroit,et al. Characterization of phosphatidylserine-dependent beta2-glycoprotein I macrophage interactions. Implications for apoptotic cell clearance by phagocytes. , 1998, The Journal of biological chemistry.
[48] N. Won,et al. MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis. , 2005, Kidney international.
[49] C. Landersdorfer,et al. Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new? , 2012, Diagnostic microbiology and infectious disease.
[50] Tso‐Hsiao Chen,et al. Leptin reduces gentamicin-induced apoptosis in rat renal tubular cells via the PI3K-Akt signaling pathway. , 2011, European journal of pharmacology.
[51] S. Nagata,et al. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD , 1998, Nature.
[52] M. Rosenberg,et al. Clusterin protects renal tubular epithelial cells from gentamicin-mediated cytotoxicity. , 2002, American journal of physiology. Renal physiology.
[53] Brian T. Tsuji,et al. Pharmacokinetic/Pharmacodynamic Investigation of Colistin against Pseudomonas aeruginosa Using an In Vitro Model , 2010, Antimicrobial Agents and Chemotherapy.
[54] Dean P. Jones,et al. Apoptosis: Cell death defined by caspase activation , 1999, Cell Death and Differentiation.
[55] G.,et al. Annexin V for Flow Cytometric Detection of Phosphatidylserine Expression on B Cells Undergoing Apoptosis , 2000 .
[56] J. Turnidge,et al. Subacute Toxicity of Colistin Methanesulfonate in Rats: Comparison of Various Intravenous Dosage Regimens , 2008, Antimicrobial Agents and Chemotherapy.
[57] J. Turnidge,et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. , 2006, The Lancet. Infectious diseases.